Abstract

The cell nucleus is a tightly regulated organelle and its architectural structure is dynamically orchestrated to maintain normal cell function. Indeed, fluctuations in nuclear size and shape are known to occur during the cell cycle and alterations in nuclear morphology are also hallmarks of many diseases including cancer. Regrettably, automated reliable tools for cell cycle staging at single cell level using in situ images are still limited. It is therefore urgent to establish accurate strategies combining bioimaging with high-content image analysis for a bona fide classification. In this study we developed a supervised machine learning method for interphase cell cycle staging of individual adherent cells using in situ fluorescence images of nuclei stained with DAPI. A Support Vector Machine (SVM) classifier operated over normalized nuclear features using more than 3500 DAPI stained nuclei. Molecular ground truth labels were obtained by automatic image processing using fluorescent ubiquitination-based cell cycle indicator (Fucci) technology. An average F1-Score of 87.7% was achieved with this framework. Furthermore, the method was validated on distinct cell types reaching recall values higher than 89%. Our method is a robust approach to identify cells in G1 or S/G2 at the individual level, with implications in research and clinical applications.

Details

Title
A machine learning approach for single cell interphase cell cycle staging
Author
Hemaxi, Narotamo 1 ; Fernandes, Maria Sofia 2 ; Moreira, Ana Margarida 3 ; Melo Soraia 2 ; Seruca Raquel 4 ; Silveira Margarida 1 ; Sanches, João Miguel 1 

 University of Lisbon, Institute for Systems and Robotics (ISR), Instituto Superior Técnico (IST), Lisbon, Portugal (GRID:grid.9983.b) (ISNI:0000 0001 2181 4263) 
 University of Porto, Epithelial Interactions in Cancer (EPIC) Group, Instituto de Investigação e Inovação em Saúde (i3S), Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226); University of Porto, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226) 
 University of Porto, Epithelial Interactions in Cancer (EPIC) Group, Instituto de Investigação e Inovação em Saúde (i3S), Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226); University of Porto, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226); University of Porto, Institute of Biomedical Sciences Abel Salazar (ICBAS), Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226) 
 University of Porto, Epithelial Interactions in Cancer (EPIC) Group, Instituto de Investigação e Inovação em Saúde (i3S), Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226); University of Porto, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226); University of Porto, Faculty of Medicine, Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2577607194
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.